Quick Answer
Cytosorbents Corp reported Long Term Debt of $16.67 million for the year ending 2025.
- Cytosorbents Corp showed an increase of +19.1% in Long Term Debt from 2024 to 2025.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2015 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2016: $4.88 million | Q3 2016: $4.48 million | Q1 2017: $3.68 million | Q2 2017: $7.94 million | Q3 2017: $6.97 million | Q1 2018: $9.87 million | Q2 2018: $9.89 million | Q3 2018: $9.92 million | Q1 2019: $8.30 million | Q2 2019: $9.16 million | Q3 2019: $11.89 million | Q1 2020: $10.92 million | Q2 2020: $8.46 million | Q3 2020: $5.99 million | Q2 2023: $5.02 million | Q3 2023: $4.20 million | Q1 2024: $1.93 million | Q2 2024: $13.67 million | Q3 2024: $13.81 million | Q1 2025: $14.19 million | Q2 2025: $14.38 million | Q3 2025: $14.57 million.
- Historical annual values: Fiscal year 2025: $16.67 million | Fiscal year 2024: $14.00 million | Fiscal year 2023: $2.54 million | Fiscal year 2022: $5.00 million | Fiscal year 2020: $0.00 | Fiscal year 2019: $13.39 million | Fiscal year 2018: $9.27 million | Fiscal year 2017: $5.99 million | Fiscal year 2016: $4.08 million | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: